Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
9-Aminocamptothecin in Untreated Gastric Cancer
NCT00003192Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Mar 1998
- Primary completion
- Feb 2002
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of 9-aminocamptothecin in gastric cancer (GC), esophageal cancer, sponsored by University of Chicago. Started Mar 1998; status: completed.
02
Drugs
9-aminocamptothecin
03
Conditions
gastric cancer (GC)esophageal cancer
Beyond the preview
Go deeper on NCT00003192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003192.